CVI Holdings’s Fortress Biotech FBIO Stock Holding History

CVI Holdings’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-764,549	Closed	-$2.3M	–	163
2023 Q4	$2.3M	Buy	+764,549	New	+$2.02M	4.76%	7

Other funds holding FBIO

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CVI Holdings's FBIO Position: Q1 2024 in Review

CVI Holdings sold out of Fortress Biotech (FBIO) in Q1 2024, closing a stake of 764,549 shares — an estimated $2.3M sold.

CVI Holdings first reported a position in FBIO in Q4 2023 and held it in 1 quarter. The position peaked at $2.3M in Q4 2023. 40 funds tracked by Wall St. Rank hold FBIO as of Q1 2024.

CVI Holdings reported no remaining Fortress Biotech position as of Q1 2024 after selling out during the quarter.
CVI Holdings sold 764,549 Fortress Biotech shares in Q1 2024, an estimated $2.3M.
CVI Holdings first reported a position in Fortress Biotech in Q4 2023 and held it in 1 quarter.
CVI Holdings's Fortress Biotech position peaked at $2.3M in Q4 2023.
40 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2024.

Based on CVI Holdings's 13F filing for Q1 2024, filed 7 May 2024.